Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2018 | Tau ligands and the future of Tau PET imaging

There are a large variety of Tau ligands available for Tau PET imaging, with new agents frequently being released. Elizabeth Mormino, PhD, of Stanford University, Stanford, CA, discussed these ligands at the Alzheimer’s Association International Conference (AAIC) 2018, held in Chicago, IL, highlighting important areas for future research in this field. She highlights the importance of establishing longitudinal studies with Tau ligands in order to understand their behavior long-term. This would allow for the most effective ligands to be identified: something that would be invaluable in long-term clinical trials. Finally, Dr Mormino discusses her own research aims with Tau PET imaging, and her hopes for identifying early Tau signals in pre-symptomatic patients to illuminate disease progression patterns.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.